# Study to Characterize the Pharmacokinetics of a Single Dose of SC Abatacept 125 mg Using the BD Autoinjector or the Prefilled Syringe

> **NCT01890473** · PHASE1 · COMPLETED · sponsor: **Bristol-Myers Squibb** · enrollment: 356 (actual)

## Conditions studied

- Rheumatoid Arthritis

## Interventions

- **DRUG:** Abatacept

## Key facts

- **NCT ID:** NCT01890473
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-07
- **Primary completion:** 2014-11
- **Final completion:** 2014-11
- **Target enrollment:** 356 (ACTUAL)
- **Last updated:** 2015-11-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01890473

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01890473, "Study to Characterize the Pharmacokinetics of a Single Dose of SC Abatacept 125 mg Using the BD Autoinjector or the Prefilled Syringe". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01890473. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*